Cerenome CNSY
NASDAQ CNSY
$2.96 +0.02 (+0.68%)
As of: Sep 3, 2026 · 3:56 PM EDT

Cerenome (CNSY) Asset Writedowns and Impairment (2010 - 2015)

Analysis

Cerenome (CNSY) Asset Writedowns and Impairment (2010 - 2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 141.52 Bn 133.66 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.69 Bn 78.69 Bn 3.93 Bn
3 Argenx Se 64.63 Bn 59.45 Bn 1.37 Bn
4 Moderna 59.30 Bn 54.16 Bn 52.00 Mn
5 Revolution Medicines 44.41 Bn 44.41 Bn -
6 BeOne Medicines 40.45 Bn 35.35 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.29 Bn 31.98 Bn 992.69 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn -
9 Insmed 27.55 Bn 26.39 Bn 358.27 Mn
10 Cerenome 20.42 Mn 11.83 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 -105,000.00
Dec 31, 2014 -42,000.00
Sep 30, 2014 290,000.00
Jun 30, 2014 371,000.00
Mar 31, 2014 465,000.00
Dec 31, 2013 203,000.00
Sep 30, 2013 750,000.00
Jun 30, 2013 101,000.00
Mar 31, 2013 87,000.00
Dec 31, 2012 45,000.00
Sep 30, 2012 80,000.00
Jun 30, 2012 43,000.00
Mar 31, 2012 -24,000.00
Dec 31, 2011 209,000.00
Sep 30, 2011 39,000.00
Jun 30, 2011 214,000.00
Mar 31, 2011 21,000.00
Dec 31, 2010 32,000.00
Sep 30, 2010 -139,000.00